PT  - JOURNAL ARTICLE
AU  - Davar, Diwakar
AU  - Cavalcante, Ludimila
AU  - Lakhani, Nehal
AU  - Moser, Justin
AU  - Millward, Michael
AU  - McKean, Meredith
AU  - Voskoboynik, Mark
AU  - Sanborn, Rachel E
AU  - Grewal, Jaspreet S
AU  - Narayan, Ajita
AU  - Patnaik, Amita
AU  - Gainor, Justin F
AU  - Sznol, Mario
AU  - Enstrom, Amanda
AU  - Blanchfield, Lori
AU  - LeBlanc, Heidi
AU  - Thomas, Heather
AU  - Chisamore, Michael J
AU  - Peng, Stanford L
AU  - Naumovski, Allison
TI  - Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)
AID  - 10.1136/jitc-2024-009474
DP  - 2024 Aug 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e009474
VI  - 12
IP  - 8
4099  - http://jitc.bmj.com/content/12/8/e009474.short
4100  - http://jitc.bmj.com/content/12/8/e009474.full
SO  - J Immunother Cancer2024 Aug 01; 12
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.